Drug Trial Radar · NCT04396236
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
Last checked: Nov 20, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
847
Actual
Start
Jun 15, 2020
Primary completion
Nov 12, 2025
Study completion Nov 12, 2025
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- May 20, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.
Conditions
- Migraine
Interventions
LasmiditanDrug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Had Freedom From Pain at 2 Hours Post-DoseTime frame: 2 hours post dose
Locations
152 sites in 15 countries. Site status is shown where the registry gives one.
Central Research Associates
Birmingham, Alabama
Rehabilitation & Neurological Services
Huntsville, Alabama
Phoenix Children's Hospital
Phoenix, Arizona
Perseverance Research Center
Scottsdale, Arizona
Center for Neurosciences
Tucson, Arizona
Arkansas Children's
Little Rock, Arkansas
Core Healthcare Group
Cerritos, California
Pine Street Pediatrics
Exeter, California
Sun Valley Research Center
Imperial, California
Miller Children's & Women's Hospital Long Beach
Long Beach, California
Sensa Health
Los Angeles, California
Orange County Research Institute - Ontario
Ontario, California
Children's Hospital Colorado
Aurora, Colorado
Colorado Springs Neurological Associates
Colorado Springs, Colorado
Yale University School of Medicine
New Haven, Connecticut
Children's National Medical Center
Washington D.C., District of Columbia
Wolfson Children's Hospital
Jacksonville, Florida
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare
Jacksonville, Florida
Biotech Pharmaceutical Group
Miami, Florida
New Horizon Research Center
Miami, Florida
Ezy Medical Research
Miami Lakes, Florida
Suncoast Clinical Research, Inc.
New Port Richey, Florida
Avanza Medical Research Center
Pensacola, Florida
Clinical Research Center of Florida
Pompano Beach, Florida
USF Health
Tampa, Florida
ForCare Clinical Research
Tampa, Florida
Palm Beach Neurology
West Palm Beach, Florida
Pediatric Neurology P.A.
Winter Park, Florida
Meridian Clinical Research, LLC
Savannah, Georgia
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia
Hawaii Pacific Neuroscience
Honolulu, Hawaii
Medical Research Partners
Ammon, Idaho
Velocity Clinical Research, Boise
Meridian, Idaho
Chicago Headache Center and Research Institute
Chicago, Illinois
Chicago Headache Center and Research Institute - Naperville
Naperville, Illinois
Qualmedica Research, LLC
Evansville, Indiana
Fort Wayne Neurological Center - West
Fort Wayne, Indiana
Josephson Wallack Munshower Neurology, PC
Indianapolis, Indiana
Deaconess Clinic - Gateway Health Center
Newburgh, Indiana
Integrated Clinical Trial Services, Inc.
West Des Moines, Iowa
Showing 40 of 152 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.